Pönicke K, Heinroth-Hoffmann I, Becker K, Osten B, Brodde O E
Institute of Pharmacology and Toxicology, Martin Luther University of Halle-Wittenberg, Halle, Germany.
Naunyn Schmiedebergs Arch Pharmacol. 1999 Sep;360(3):301-8. doi: 10.1007/s002109900077.
Our recent findings indicate that, in rat neonatal ventricular cardiomyocytes, endothelin-1 (ET-1) induces increases in the rate of protein synthesis in a partly pertussis toxin (PTX)-sensitive manner, and that angiotensin II-evoked increases in the rate of protein synthesis are brought about via local secretion of ET-1. The aim of this study was to find out: (1) whether noradrenaline (NA) and the thromboxane A2 (TXA2)-mimetic U 46619-induced increases in the rate of protein synthesis may be also partly PTX-sensitive and/or mediated by ET-1, and (2) whether the growth-promoting effects of NA and U 46619 as well as ET-1 might involve activation of the same set of protein kinase C (PKC) isozymes. For this purpose we first studied the effects of NA and U 46619 on inositol phosphate (IP)-formation (assessed as accumulation of total [3H]IPs in myo-[3H]inositol prelabelled cells) and on the rate of protein synthesis (assessed as [3H]phenylalanine incorporation) (1) in the presence and absence of the ET(A)-receptor antagonist BQ-123, and (2) in nontreated and PTX-pretreated cells. Second, we assessed the effects of the PKC-inhibitors bisindolylmaleimide I and Gö 6976 and of phorbol-12-myristate-13-acetate (PMA; 1 microM overnight)-pretreatment on U 46619-, NA- and ET-1-induced increases in the rate of protein synthesis. NA (0.01-10 microM) concentration-dependently increased IP-formation (maximum increase: 115-/+23% above basal, n=4) and [3H]phenylalanine incorporation (maximum increase: 40+/-3% above basal, n=20). Both responses were antagonized by the alpha1-adrenoceptor antagonist prazosin (1 microM), but were not significantly affected by BQ-123 (1 microM). U 46619 (0.01-100 microM) concentration-dependently increased IP-formation (maximum increase: 89+/-12% above basal, n=8) and [3H]phenylalanine incorporation (maximum increase: 33+/-4% above basal, n=16). Both responses were slightly but significantly antagonized by the TP-receptor antagonist SQ 29548 (1 microM), but were not affected by BQ-123 (1 microM). Pretreatment of the cardiomyocytes with 250 ng ml(-1) PTX overnight did not significantly affect NA- and U 46619-evoked increases in IP-formation and [3H]phenylalanine incorporation. The PKC-inhibitor bisindolylmaleimide I (5 microM) as well as pretreatment of the cells with PMA (1 microM) significantly reduced the effects of NA, U 46619 and ET- I on the rate of protein synthesis; in contrast, the PKC-inhibitor Gö 6976 (5 microM) was without any effects. We conclude that, in rat neonatal ventricular cardiomyocytes, stimulation of Gq/11-coupled receptors increases the rate of protein synthesis; this involves activation of the same PKC-isozymes (very likely PKC-delta and/or -epsilon). NA and U 46619 cause their growth-promoting effects in a PTX-insensitive manner; ET-1 is not involved in their effects.
我们最近的研究结果表明,在大鼠新生心室心肌细胞中,内皮素-1(ET-1)以部分百日咳毒素(PTX)敏感的方式诱导蛋白质合成速率增加,并且血管紧张素II引起的蛋白质合成速率增加是通过ET-1的局部分泌实现的。本研究的目的是查明:(1)去甲肾上腺素(NA)和血栓素A2(TXA2)模拟物U 46619诱导的蛋白质合成速率增加是否也可能部分对PTX敏感和/或由ET-1介导,以及(2)NA、U 46619以及ET-1的促生长作用是否可能涉及同一组蛋白激酶C(PKC)同工酶的激活。为此,我们首先研究了NA和U 46619对肌醇磷酸(IP)形成(以[3H]肌醇预标记细胞中总[3H]IPs的积累来评估)和蛋白质合成速率(以[3H]苯丙氨酸掺入来评估)的影响:(1)在存在和不存在ET(A)受体拮抗剂BQ-123的情况下,以及(2)在未处理和PTX预处理的细胞中。其次,我们评估了PKC抑制剂双吲哚马来酰亚胺I和Gö 6976以及佛波醇-12-肉豆蔻酸酯-13-乙酸酯(PMA;1 microM过夜)预处理对U 46619、NA和ET-1诱导的蛋白质合成速率增加的影响。NA(0.01 - 10 microM)浓度依赖性地增加IP形成(最大增加:比基础值高115±23%,n = 4)和[3H]苯丙氨酸掺入(最大增加:比基础值高40±3%,n = 20)。这两种反应均被α1肾上腺素能受体拮抗剂哌唑嗪(1 microM)拮抗,但不受BQ-123(1 microM)的显著影响。U 46619(0.01 - 100 microM)浓度依赖性地增加IP形成(最大增加:比基础值高89±12%,n = 8)和[3H]苯丙氨酸掺入(最大增加:比基础值高33±4%,n = 16)。这两种反应均被TP受体拮抗剂SQ 29548(1 microM)轻微但显著地拮抗,但不受BQ-123(1 microM)的影响。用250 ng/ml PTX对心肌细胞进行过夜预处理并没有显著影响NA和U 46619引起的IP形成和[3H]苯丙氨酸掺入增加。PKC抑制剂双吲哚马来酰亚胺I(5 microM)以及用PMA(1 microM)对细胞进行预处理显著降低了NA、U 46619和ET-1对蛋白质合成速率的影响;相比之下,PKC抑制剂Gö 6976(5 microM)没有任何作用。我们得出结论,在大鼠新生心室心肌细胞中,刺激Gq/11偶联受体可增加蛋白质合成速率;这涉及同一PKC同工酶(很可能是PKC-δ和/或-ε)的激活。NA和U 46619以PTX不敏感的方式发挥其促生长作用;ET-1不参与它们的作用。